11:15am - 12:15pm Monday, March 9

Location & Room

Orlando - Orange County Convention Center
W307A
Additional Registration
Extra Fee
Blockchain will transform the way companies exchange data and execute business processes between trading partners.  The MediLedger Project was started in 2017, bringing leading Pharma and Life Science companies together to better understand how blockchain powered solutions could enable compliance with the Drug Supply Chain Security Act (DSCSA).  The work has grown beyond pilot to live, commercial  decentralized solutions to verify drugs, and to also start looking at ROI opportunities in the revenue management processes associated with the sale of medicine.  This session will provide an overview of the work to date, potential impact of blockchain based solutions on how companies operate, and lessons learned along the way.
Speakers: 
CEO,
Chronicled
Continuing Education Credits: 
CAHIMS
1.00
CME
1.00
CNE
1.00
CPHIMS
1.00